BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Alkermes and Clovis Oncology Initiate Research Collaboration to Explore Combination Cancer Therapies

  Combinations of ALKS 4230 with Rucaparib and Lucitanib to be Evaluated in Multiple Preclinical Tumor Models

  February 19, 2019

   · 

  9 min read
• Deals

  Bausch Health Acquires Eton Pharmaceuticals’ EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies

  If Approved, EM-100 Will Be the First OTC Preservative-Free Formulation of Its Kind

  February 19, 2019

   · 

  5 min read
• BioForest

  Choom Completes Buildout of E-Commerce Platform

  Choom™ a Canadian cannabis retail company, is pleased to announce the completion of its e-commerce platform.

  February 19, 2019

   · 

  3 min read
• Business

  Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Monday, February 25, 2019

  Aerie Pharmaceuticals, Inc. announced that its fourth quarter and full year 2018 financial results will be released after the market closes on Monday, February 25, 2019.

  February 19, 2019

   · 

  3 min read
• Business

  NextGate and e4 Partner to Advance Positive Patient Identification and EHR Data Integrity

  Partnership to support healthcare delivery organizations with a pragmatic approach to accurate patient matching and medical record remediation

  February 19, 2019

   · 

  3 min read
• Policy

  Gilead Receives Approval in Canada for YESCARTA™ (Axicabtagene Ciloleucel) CAR T Therapy for Adults With Relapsed or Refractory Large B-cell Lymphoma After Two or More Lines of Systemic Therapy

  YESCARTA is a chimeric antigen receptor T (CAR T) cell therapy that is custom-made for each patient from his or her own T cells.

  February 19, 2019

   · 

  14 min read
• BioForest

  Five Myths and Facts About Cancer Prevention

  The American Institute for Cancer Research (AICR) is leading a national campaign to help Americans separate the myths from facts about cancer risk.

  February 19, 2019

   · 

  3 min read
• Pharm Country

  Researchers suggest balanced reporting of sports head injuries

  A group of more than 60 leading international neuroscientists published a correspondence last week in The Lancet Neurology, asking for balance when reporting on sports-related injury chronic traumatic encephalopathy.

  February 19, 2019

   · 

  2 min read
• Business

  MORE Health Announces Partnership with Fox Chase Cancer Center to offer Patients Remote Second Opinions

  Fox Chase Cancer Center and MORE Health, a global healthcare company, announced a cutting-edge partnership that gives patients from across the world access to the nationally ranked physicians of Fox Chase Cancer Center through MORE Health’s Physician Collaboration Platform™.

  February 19, 2019

   · 

  3 min read
• Deals

  Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019

  Ophthotech Corporation announced that it will report its fourth quarter and full year 2018 financial and operating results on Tuesday, February 26, 2019.

  February 19, 2019

   · 

  1 min read